Why Israeli Companies Still Dual-List
Nasdaq for valuation. TASE for inclusion, distribution, and tax. The economic logic of why Israeli growth companies maintain both listings.
Nasdaq for valuation. TASE for inclusion, distribution, and tax. The economic logic of why Israeli growth companies maintain both listings.
Dual listing — primary on a major U.S. or European exchange, secondary on the Tel Aviv Stock Exchange — has been the default structure for large Israeli growth companies for two decades. The logic is unchanged.
Why It Matters
- Nasdaq for valuation, liquidity, and U.S. investor access
- TASE for TA-35 inclusion and Israeli institutional buying
- Section 102 cleaner tax treatment for Israeli employees
- Domestic retail can access TASE shares directly
- Pension and savings vehicles allocate higher to TASE-listed names
Why companies primary-list on the Nasdaq (or NYSE)
Liquidity. U.S. equity markets offer dramatically deeper daily trading volume than the TASE, particularly for technology and growth names.
Valuation. U.S. comparable analysis typically yields higher multiples for high-growth Israeli technology companies than Israeli comparable analysis.
Investor base. U.S. institutional investors — the largest pool of global growth equity capital — concentrate analyst coverage and capital allocation on U.S.-listed names.
Capital raising. Follow-on offerings and convertible issuance are deeper and more execution-friendly in U.S. markets.
Why companies secondary-list on the TASE
TA-35 inclusion. Inclusion in the TASE blue-chip index forces Israeli institutional buying — the Big Five insurers and the leading asset houses passively or semi-passively track Israeli indices.
Domestic retail access. Israeli retail investors can buy TASE-listed shares without navigating U.S. brokerage and tax compliance friction.
Employee compensation. Israeli employees receiving stock-based compensation face cleaner tax treatment on TASE-listed shares under Section 102 of the Israeli Income Tax Ordinance.
Israeli capital allocation. Israeli institutional capital — pension funds, gemel, keren hishtalmut — has structurally higher allocation to TASE-listed names than to dual-listed names quoted in foreign currency.
Where the pattern breaks down
- Pure global growth companies sometimes skip the TASE entirely, especially when founder and management are U.S.-based and the Israeli operating presence is limited.
- Pure domestic Israeli businesses — banks, insurers, real estate developers, telecom, utilities — typically primary-list only on the TASE.
- Reverse pattern — Israeli companies primary-listing in Israel and secondary-listing in the U.S. — exists but is rare.
The bottom line
Dual listing reflects an economic reality: Israeli growth companies operate in two capital markets simultaneously. The Nasdaq listing prices the company globally. The TASE listing captures Israeli institutional and retail demand and embeds the company in the domestic capital allocation system.
Two listings. Two capital markets. One company.
FAQ
Why do Israeli companies dual-list on Nasdaq and TASE?
Nasdaq for liquidity, valuation, and U.S. investor access. TASE for index inclusion, domestic retail access, Israeli institutional capital, and favorable employee compensation tax treatment.
What is dual listing?
Dual listing is the practice of having a company's shares simultaneously listed on two exchanges. For Israeli growth companies, this typically means a primary U.S. listing (Nasdaq or NYSE) and a secondary TASE listing.
Do all Israeli tech companies dual-list?
No. Many Israeli technology companies list only on the Nasdaq. Dual listing is more common among larger Israeli growth names with material Israeli operations and Israeli investor demand.
What are the benefits of a TASE listing for a U.S.-listed Israeli company?
TA-35 index inclusion forces Israeli institutional buying. Israeli retail can access shares directly. Section 102 stock-based compensation treatment for Israeli employees is cleaner. Israeli institutional capital allocations are higher to TASE-listed names.
